Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

Published:2010-05 Issue:18 Volume:55 Page:1915-1922
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

McLaughlin Vallerie V.,Benza Raymond L.,Rubin Lewis J.,Channick Richard N.,Voswinckel Robert,Tapson Victor F.,Robbins Ivan M.,Olschewski Horst,Rubenfire Melvyn,Seeger Werner

Funder

United Therapeutics Corporation

Actelion Pharmaceuticals, Encysive, Pfizer

United Therapeutics Corp.

Gilead Sciences

Actelion Pharmaceuticals

Lung Rx, Inc.

Actelion Pharmaceuticals, Gilead Sciences

Gilead Sciences, Actelion Pharmaceuticals

Deutsche Forschungsgemeinschaft

Osterreichische Nationalbank

European Union Framework 5 and 6

Schering AG, Unither

Actelion Pharmaceuticals and Encysive

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association;McLaughlin;J Am Coll Cardiol,2009

2. Updated evidence-based treatment algorithm in pulmonary arterial hypertension;Barst;J Am Coll Cardiol,2009

3. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension;Barst;N Engl J Med,1996

4. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial;Simonneau;Am J Respir Crit Care Med,2002

5. Inhaled iloprost for severe pulmonary hypertension;Olschewski;N Engl J Med,2002

Cited by 472 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil;JHLT Open;2024-11

2. New Therapies in Outpatient Pulmonary Medicine;Medical Clinics of North America;2024-09

3. Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective;American Journal of Respiratory and Critical Care Medicine;2024-09-01

4. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

5. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27